Role of Homoeopathy In Prostatic Complaints

A Comparative Study Of The Efficacy Of Homoeopathic Medicines In Cases Of Benign Prostatic Hyperplasia On The Basis Of Totality Of Symptoms And Pathological Similie - NILL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053956

Enrollment

100

Registered

2023-06-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N40- Benign prostatic hyperplasia

Interventions

Intervention1: Homoeopathic Medicine: Medicine is selected on the basis of individualized homoeopathic approach Control Intervention1: Homoeopathic Medicine: Medicine is selected on the basis of patho

Eligibility

Inclusion criteria

Inclusion criteria: 1. All males of 40 years to 80 years of age. 2. Patients giving voluntary consent for the study. 3. Cases of Benign Prostatic Hyperplasia (ICD 10- N40) with at least 3 out of following symptoms : A. Frequency B. Incomplete emptying C. Nocturia D. Intermittency E. Urgency F. Pain (Dysuria) G. Haematuria H. Straining I. Retention of urine (not more than 24 hrs). 4. Pre diagnosed cases of Benign Prostatic Hyperplasia are under modern medicine treatment but have no relief seeking for homoeopathic treatment.

Exclusion criteria

Exclusion criteria: 1. Cases who refuses to give informed consent for the study. 2. Cases with intolerable pain or complicated with obstruction. 3. Cases with any stricture which caused obstruction. 4. Cases without proper followâ??up will be excluded from the study. 5. Cases undergone bladder surgeries 6. Carcinoma of prostate 7. Complete urine retention for more than 24 hours. 8. Cases having any other complications of Benign Prostatic Hyperplasia.

Design outcomes

Primary

Measure	Time frame
According to the scores obtained (pre & post treatment) from the IPSSTimepoint: According to the scores obtained from the IPSS at every 6 weeks	—

Secondary

Measure	Time frame
To compare the efficacy of Homoeopathic Medicines in cases of Benign Prostatic Hyperplasia on the basis of totality of symptoms & Pathological SimilieTimepoint: 12 Months	—

Countries

India

Contacts

Public ContactDr Hari Shankar Tiwari

Homoeopathy University

raghavdrsn@gmail.com9414320633

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026